Literature DB >> 2504437

Protective effect of cyclohexyladenosine on adenosine A1-receptors, guanine nucleotide and forskolin binding sites following transient brain ischemia: a quantitative autoradiographic study.

J L Daval1, D K Von Lubitz, J Deckert, D J Redmond, P J Marangos.   

Abstract

The effects of an i.p. administration of cyclohexyladenosine (CHA) have been examined upon ischemic brain damage in gerbils. Ischemia was induced for 20 min by occlusion of both carotid arteries, and CHA was administered 5 min after recirculation at a dose of 2 mg/kg. Animals were sacrificed either 1, 3 or 6 days after ischemia and their brains were used for examination of cell morphology and quantitative autoradiography. In animals subject to ischemia, the deterioration of the laminar organization of the hippocampus was associated with a significant decrease in adenosine A1-receptors (labeled with [3H]CHA), G-protein (labeled with [3H]forskolin). The treatment with CHA considerably improved the morphological preservation of cells in the CA1 region of the hippocampus and prevented the reduction in the specific binding of all radioligands. Adenosine, its analogues and other substances modulating adenosine receptors may thus provide new therapeutic approaches to the treatment of ischemia-induced brain injury.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504437     DOI: 10.1016/0006-8993(89)90058-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  The second extracellular loop of the adenosine A1 receptor mediates activity of allosteric enhancers.

Authors:  Dylan P Kennedy; Fiona M McRobb; Susan A Leonhardt; Michael Purdy; Heidi Figler; Melissa A Marshall; Mahendra Chordia; Robert Figler; Joel Linden; Ruben Abagyan; Mark Yeager
Journal:  Mol Pharmacol       Date:  2013-11-11       Impact factor: 4.436

2.  Prediction of consensus binding mode geometries for related chemical series of positive allosteric modulators of adenosine and muscarinic acetylcholine receptors.

Authors:  Leon A Sakkal; Kyle Z Rajkowski; Roger S Armen
Journal:  J Comput Chem       Date:  2017-01-28       Impact factor: 3.376

3.  CNS adenosine A1 receptors are altered after the administration of convulsant 3-mercaptopropionic acid and cyclopentyladenosine: an autoradiographic study.

Authors:  L Giraldez; F Zanetti; M C Antonelli; G Rodríguez de Lores Arnaiz; E Girardi
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

4.  Cerebral ischemia in gerbils: postischemic administration of cyclohexyl adenosine and 8-sulfophenyl-theophylline.

Authors:  D K von Lubitz; P J Marangos
Journal:  J Mol Neurosci       Date:  1990       Impact factor: 3.444

Review 5.  Tryptophan, adenosine, neurodegeneration and neuroprotection.

Authors:  T W Stone; C M Forrest; G M Mackay; N Stoy; L G Darlington
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

6.  Changes in extracellular adenosine levels and population spike amplitude during graded hypoxia in the rat hippocampal slice.

Authors:  J C Fowler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-01       Impact factor: 3.000

7.  Effects of chronic administration of adenosine A1 receptor agonist and antagonist on spatial learning and memory.

Authors:  D K Von Lubitz; I A Paul; R T Bartus; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1993-11-16       Impact factor: 4.432

Review 8.  Ionotropic receptors and ion channels in ischemic neuronal death and dysfunction.

Authors:  Nicholas L Weilinger; Valentyna Maslieieva; Jennifer Bialecki; Sarup S Sridharan; Peter L Tang; Roger J Thompson
Journal:  Acta Pharmacol Sin       Date:  2012-08-06       Impact factor: 6.150

9.  Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.

Authors:  Tejbeer Kaur; Vikrant Borse; Sandeep Sheth; Kelly Sheehan; Sumana Ghosh; Srinivasan Tupal; Sarvesh Jajoo; Debashree Mukherjea; Leonard P Rybak; Vickram Ramkumar
Journal:  J Neurosci       Date:  2016-04-06       Impact factor: 6.167

Review 10.  Adenosine: a prototherapeutic concept in neurodegeneration.

Authors:  D K von Lubitz; M F Carter; M Beenhakker; R C Lin; K A Jacobson
Journal:  Ann N Y Acad Sci       Date:  1995-09-15       Impact factor: 5.691

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.